Stay updated on Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial page.

Latest updates to the Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA new revision entry (v3.6.4) was added to the history, representing an update to the study record. The previous revision (v3.6.3) was removed from the change log.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedA new revision entry (v3.6.3) was added to the history, and the previous revision (v3.6.2) was removed from the current listing, updating the page's version history.SummaryDifference0.1%

- Check38 days agoChange DetectedA new revision entry v3.6.2 was added to the history, and the previous entry v3.6.0 was removed, updating the study's submission record.SummaryDifference0.1%

- Check52 days agoChange DetectedThe history now shows recruitment status updated to no longer looking for participants and a new Revision: v3.6.0 added, replacing the previous Revision: v3.5.5.SummaryDifference0.3%

- Check59 days agoChange DetectedA new revision entry v3.5.5 appears in the study record history, and the previous revision v3.5.4 is no longer listed. This change updates the history log metadata for the record.SummaryDifference0.1%

- Check81 days agoChange DetectedA new page revision tag, v3.5.4, was added to the history, replacing the previous tag, v3.5.3. This indicates a version update to the page rendering rather than changes to the study data or text.SummaryDifference0.1%

Stay in the know with updates to Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial page.